Literature DB >> 17928087

Transport mechanisms of mmePEG750P(CL-co-TMC) polymeric micelles across the intestinal barrier.

Frédéric Mathot1, A des Rieux, A Ariën, Y-J Schneider, M Brewster, V Préat.   

Abstract

Monomethylether poly(ethyleneglycol)(750)-poly(caprolactone-co-trimethylene carbonate) (mmePEG750)P(CL-co-TMC)) which spontaneously form micelles, can cross lipid bilayers via passive diffusion and demonstrate an oral bioavailability of 40% in rats. The aim of the current work was to study the transport mechanism(s) of drug-loaded mmePEG750P(CL-co-TMC) micelles across the intestinal barrier. The transport of radiolabelled polymer across Caco-2 cell monolayer was investigated by disrupting tight junctions and by inhibiting endocytosis. The polymer and drugs loaded in micelles independently crossed Caco-2 cell monolayers and did not use either the paracellular route or M-cells. The polymer did not affect P-gp pumps. This mechanistic study suggests that whereas drug-loaded micelles were absorbed by fluid-phase endocytosis, polymeric unimers diffused passively across the membrane concomitantly with micellar endocytosis.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17928087     DOI: 10.1016/j.jconrel.2007.09.001

Source DB:  PubMed          Journal:  J Control Release        ISSN: 0168-3659            Impact factor:   9.776


  9 in total

1.  Vorinostat with sustained exposure and high solubility in poly(ethylene glycol)-b-poly(DL-lactic acid) micelle nanocarriers: characterization and effects on pharmacokinetics in rat serum and urine.

Authors:  Elham A Mohamed; Yunqi Zhao; Mahasen M Meshali; Connie M Remsberg; Thanaa M Borg; Abdel Monem M Foda; Jody K Takemoto; Casey L Sayre; Stephanie E Martinez; Neal M Davies; M Laird Forrest
Journal:  J Pharm Sci       Date:  2012-07-17       Impact factor: 3.534

2.  Novel mixed polymeric micelles for enhancing delivery of anticancer drug and overcoming multidrug resistance in tumor cell lines simultaneously.

Authors:  Xinru Li; Pingzhu Li; Yanhui Zhang; Yanxia Zhou; Xingwei Chen; Yanqing Huang; Yan Liu
Journal:  Pharm Res       Date:  2010-04-23       Impact factor: 4.200

3.  Folic acid functionalized nanoparticles for enhanced oral drug delivery.

Authors:  Emilie Roger; Stephen Kalscheuer; Ameya Kirtane; Bharath Raja Guru; Alex E Grill; Judith Whittum-Hudson; Jayanth Panyam
Journal:  Mol Pharm       Date:  2012-06-13       Impact factor: 4.939

4.  Preparation and evaluation of poly(ethylene glycol)-poly(lactide) micelles as nanocarriers for oral delivery of cyclosporine a.

Authors:  Yanhui Zhang; Xinru Li; Yanxia Zhou; Xiaoning Wang; Yating Fan; Yanqing Huang; Yan Liu
Journal:  Nanoscale Res Lett       Date:  2010-03-27       Impact factor: 4.703

Review 5.  Polymeric micelles and alternative nanonized delivery vehicles for poorly soluble drugs.

Authors:  Ying Lu; Kinam Park
Journal:  Int J Pharm       Date:  2012-08-25       Impact factor: 5.875

6.  The effect of dual-functional hyaluronic acid-vitamin E succinate micelles on targeting delivery of doxorubicin.

Authors:  Jinling Wang; Wenzhuan Ma; Qiang Guo; Ying Li; Zhongdong Hu; Zhixiang Zhu; Xiaohui Wang; Yunfang Zhao; Xingyun Chai; Pengfei Tu
Journal:  Int J Nanomedicine       Date:  2016-11-07

7.  Enhanced oral bioavailability of magnolol via mixed micelles and nanosuspensions based on Soluplus®-Poloxamer 188.

Authors:  Guoyuan Li; Yuting Lu; Yongchun Fan; Qing Ning; Weiguang Li
Journal:  Drug Deliv       Date:  2020-12       Impact factor: 6.419

8.  Afatinib and its encapsulated polymeric micelles inhibits HER2-overexpressed colorectal tumor cell growth in vitro and in vivo.

Authors:  Siao-Syun Guan; Jungshan Chang; Chun-Chia Cheng; Tsai-Yueh Luo; Ai-Sheng Ho; Chia-Chi Wang; Cheng-Tien Wu; Shing-Hwa Liu
Journal:  Oncotarget       Date:  2014-07-15

9.  A composite nanocarrier to inhibit precipitation of the weakly basic drug in the gastrointestinal tract.

Authors:  Chunli Zheng; Yun Li; Zhen Peng; Xinyi He; Juan Tao; Liang Ge; Yixin Sun; Yunkai Wu
Journal:  Drug Deliv       Date:  2020-12       Impact factor: 6.419

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.